Medtronic Completes Acquisition of Scientia Vascular for $550M

Medtronic successfully completes its acquisition of Scientia Vascular, adding a new layer to its neurovascular care offerings. This acquisition was for $550 million.

Medtronic has completed its acquisition of Scientia Vascular, expanding its portfolio in neurovascular care. This acquisition comes after other reports confirmed the completion of the deal for a $550 million price tag.

By seamlessly integrating the access and therapeutic portfolios of Scientia Vascular, Medtronic aims to enhance its offerings in neurovascular care.

The deal size remains consistent across available reports, with each indicating a $550 million acquisition price.

For MDT, the bolt-on deepens its neurovascular franchise with Scientia advanced microcatheter and access technologies used in treating strokes and brain aneurysms, a high-growth area where procedure volumes are rising. At $550 million the acquisition is modest relative to Medtronic scale, positioning it as a capability tuck-in rather than a needle-moving financial event. Investors will watch integration progress and whether the added access portfolio accelerates Medtronic neurovascular revenue growth.